e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Quality management for lung cancer patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of German national lung cancer guideline quality indicators in routine practice – Does the new TNM-system make a difference?
T. Blum, J. Kollmeier, N. Schönfeld, W. Ammenwerth, S. Delis, W. Grüning, W. Nehls, T. T. Bauer (Berlin, Germany)
Source:
Annual Congress 2011 - Quality management for lung cancer patients
Session:
Quality management for lung cancer patients
Session type:
Thematic Poster Session
Number:
4424
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Blum, J. Kollmeier, N. Schönfeld, W. Ammenwerth, S. Delis, W. Grüning, W. Nehls, T. T. Bauer (Berlin, Germany). Assessment of German national lung cancer guideline quality indicators in routine practice – Does the new TNM-system make a difference?. Eur Respir J 2011; 38: Suppl. 55, 4424
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Evaluation of a simplified new score of quality of life for the assessment of COPD patients in general medicine – A prospective study
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Current screening programs for lung cancer – Are inclusion criteria too rigorous to identify asymptomatic patients?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Quality evaluation of primary care referrals to lung cancer services and their response in South London: Clinical practice in a pragmatic setting.
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Assessing the local impact of a national lung cancer awareness campaign
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
The value of a UK regional mesothelioma multidisciplinary team meeting – An audit
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Does registration of performance indicators improve health outcomes in COPD?
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
The European initiative for quality management in lung cancer care
Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines
Year: 2014
The European initiative for quality management in lung cancer care
Source: Guideline 2014
Year: 2014
The European initiative for quality management in lung cancer care
Source: Eur Respir J 2014; 43: 1254-1277
Year: 2014
Validation of the COPD lung cancer screening score in a community based cohort of COPD patients
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Clinical management of lung cancer in France: a national survey
Source: Eur Respir J 2001; 18: Suppl. 33, 228s
Year: 2001
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
Quality of life & clinical outcomes following referral to a specialist bronchiectasis service
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Lung cancer screening - what does it mean for our practice?
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – paediatric findings
Source: Eur Respir J 2006; 28: Suppl. 50, 480s
Year: 2006
Impact of two spirometry training programs on test quality in Dutch general practices
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Management of COPD in general practice in Denmark – can participating in an educational programme improve adherence to guidelines?
Source: Annual Congress 2008 - COPD
Year: 2008
Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages?
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Nursing personal & respiratory cancer care: field experiences of Indian cancer N.G.O.
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
The influence of the UK national lung cancer campaign on fast-track referrals to secondary care
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept